Last reviewed · How we verify
NCT03563404
Portal Blood Flushes in the Peri-Reperfusion Stage of Liver Transplantation
trial in Liver Disease in 20 participants. Completed in 29 June 2016.
29 June 2016
Quick facts
| Lead sponsor | Medical University of South Carolina |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 20 |
| Start date | 29 June 2015 |
| Primary completion | 29 June 2016 |
| Estimated completion | 29 June 2016 |
| Sites | 1 location across United States |
Conditions studied
- Liver Disease — all drugs for Liver Disease →
Sponsor
Medical University of South Carolina
Who can join
18 and older, any sex, with Liver Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
By showing that increased levels of acidotic metabolites and electrolytes in the systemic blood of patients who do not receive portal blood flush prior to reperfusion compared to patients who do receive portal blood flush, and that these increased levels correlate with cardiac depression as seen on TEE, the investigators hope to find a superior technique for liver reperfusion.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Post-Reperfusion Syndrome in Liver Transplantation: Does a Caval Blood Flush Vent Help?
Stoll WD, Hand WR, Chavin KD, Felton DH, et al · · 2019 · cited 6× · PMID 31831725 · DOI 10.12659/aot.920193
Verify or expand the search:
- PubMed search for NCT03563404
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Liver Disease
Currently open trials in the same condition.
- NCT04014413 — Safety and Efficacy of Fecal Microbiota Transplantation · NA · recruiting
- NCT02382822 — Copenhagen Comorbidity in HIV Infection Study · active not recruiting
- NCT00001971 — Evaluation of Patients With Liver Disease · recruiting
Other Medical University of South Carolina trials
Trials by the same sponsor.
- NCT06491264 — Multiparameter Optimized tES for Memory in Aging · NA · withdrawn
- NCT07513389 — Omission of Postoperative Radiation in HPV-Associated Oropharyngeal Cancer Using ctHPVDNA Surveillance (OPERATION) · Phase 2 · not yet recruiting
- NCT03101917 — Microtable® Method for Cochlear Implantation Investigational Device Exemption (IDE) · NA · not yet recruiting
- NCT07149207 — Intraoperative Molecular Imaging Using ICG for Head and Neck Tumors · Phase 2 · recruiting
- NCT06148038 — CBD for Breast Cancer Primary Tumors · Phase 1 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03563404 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Medical University of South Carolina
- Last refreshed: 3 July 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03563404.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing